Literature DB >> 31201392

Ripretinib turns off the switch in GIST.

M Teresa Villanueva1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31201392     DOI： 10.1038/s41568-019-0167-z

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  2 in total

1.  Preclinical model-based evaluation of Imatinib resistance induced by KIT mutations and its overcoming strategies in gastrointestinal stromal tumor (GIST).

Authors:  Qian Zhao; Cheng Zhang; Changsong Qi; Jing Yang; Yang Chen; Sai Ge; Lin Shen; Jing Gao; Jian Li
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Analysis of clinicopathologic features and gene mutations in gastrointestinal stromal tumor: a series of 58 patients.

Authors:  Hao Cheng; Tian Qiu; Su-Sheng Shi
Journal:  Int J Clin Exp Pathol       Date:  2021-12-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.